How is colorectal cancer best prevented?

Written in association with: Dr Jamie Mills
Published: | Updated: 01/08/2024
Edited by: Conor Lynch

In this article below, distinguished consultant clinical oncologist, Dr Jamie Mills, provides us with an all-you-need-to-know guide with regards to colorectal cancer.

What is colorectal cancer?

Colorectal cancer, also known as bowel cancer, is a type of cancer that begins in the colon or rectum. It is one of the most common cancers worldwide, affecting both men and women, typically over the age of 50. The disease often starts as benign clumps of cells called polyps, which can develop on the inner lining of the colon or rectum. Over time, some of these polyps can become cancerous.

 

What causes colorectal cancer?

The exact cause of colorectal cancer is not entirely understood, but several risk factors have been identified. These include age, a personal or family history of colorectal cancer or polyps, inflammatory bowel diseases like Crohn's disease or ulcerative colitis, and certain genetic syndromes such as Lynch syndrome or familial adenomatous polyposis. Lifestyle factors also play a significant role. Diets high in red and processed meats, low physical activity, obesity, smoking, and heavy alcohol use can increase the risk of developing colorectal cancer.

 

What are the associated symptoms?

Symptoms of colorectal cancer can be subtle and often do not appear until the disease has progressed. Common signs include changes in bowel habits, such as diarrhoea, constipation, or narrowing of the stool that lasts for more than a few days.

 

Other symptoms may include rectal bleeding or blood in the stool, persistent abdominal discomfort such as cramps, gas, or pain, a feeling that the bowel does not empty completely, weakness or fatigue, and unexplained weight loss.

 

How effective is colorectal cancer screening, and how often should I go for screening?

Screening for colorectal cancer is highly effective and can significantly reduce mortality rates. Methods include stool tests, flexible sigmoidoscopy, colonoscopy, and CT colonography. Regular screening is recommended starting at age 50 for most people, but those with higher risk factors may need to begin earlier.

 

How is colorectal cancer treated?

Treatment for colorectal cancer depends on the stage of the disease. Early-stage cancer may be treated with surgery alone, which involves removing the cancerous polyps or sections of the colon. More advanced cancers may require a combination of surgery, radiation therapy, and chemotherapy. Targeted therapies and immunotherapies are also being used to treat certain types of colorectal cancer.

 

How is colorectal cancer best prevented?

Prevention strategies include maintaining a healthy diet rich in fruits, vegetables, and whole grains, regular physical activity, limiting alcohol consumption, avoiding tobacco use, and undergoing regular screenings.

 

To consult with Dr Jamie Mills today, just visit his Top Doctors profile. 

By Dr Jamie Mills
Clinical oncology

Dr Jamie Mills is a distinguished consultant clinical oncologist renowned for his expertise in the diagnosis and treatment of colorectal and anal cancers, alongside prostate cancer and bladder cancers, using stereotactic ablative body radiotherapy (SAB), including oligometastatic disease, specialised radiotherapy, immunotherapy, chemotherapy, and hormonal therapy.

Dr Mills successfully completed an MB ChB at the University of Leicester in 2000, followed by specialised training in oncology. His postgraduate education included rigorous residency and fellowship programmes at leading medical institutions throughout the UK, where he honed his skills in oncology and gained comprehensive knowledge of cancer biology, radiotherapy, and chemotherapy.

His education also included advanced training in innovative cancer treatment techniques and patient-centred care. Dr Mills is actively involved in oncological research, contributing to numerous studies and publications that advance the understanding and treatment of cancer. His main research interests include the development of novel therapeutic approaches, optimising radiation therapy protocols, and exploring the molecular underpinnings of cancer.

Dr Mills, to date, has published extensively in peer-reviewed journals, presenting his findings at national and international conferences. He is also a member of several professional organizations, including the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO). These affiliations keep him at the forefront of oncological advancements and provide him with a platform to collaborate with peers and contribute to the ongoing development of cancer treatments.

View Profile

Overall assessment of their patients


  • Related procedures
  • Mouth cancer
    Prostate cancer
    Human papillomavirus (HPV)
    Human papillomavirus vaccine (HPV)
    Breast cancer
    Brain tumour
    Testicular cancer
    Thyroid cancer
    Adrenal glands cancer
    Doppler Ultrasound
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.